Overview
Uvular hypertrophy refers to the enlargement of the uvula, which can lead to symptoms such as dysphagia, snoring, and sleep apnea. It is often associated with anatomical variations or secondary to other conditions like chronic irritation or inflammation 1.Diagnosis
Clinical examination revealing enlarged uvula size
Flexible nasopharyngoscopy to visualize the uvula and assess for associated anatomical abnormalities
Imaging studies (e.g., MRI, CT) may be considered in complex cases to rule out other pathologies 1Management
First-line treatments: Address underlying causes (e.g., reducing irritants, managing GERD)
Adjunctive treatments: Surgical intervention (uvulectomy) may be necessary for symptomatic relief in severe cases 1Special Populations
Elderly: Consider comorbidities and functional status when evaluating surgical options 1
Comorbidities: Management should focus on alleviating symptoms impacting sleep apnea or swallowing difficulties, potentially integrating care with ENT specialists 1Key Recommendations
Identify and manage underlying causes contributing to uvular hypertrophy to prevent symptom exacerbation (Evidence: Expert opinion) 1
Consider flexible nasopharyngoscopy for definitive diagnosis and assessment of anatomical impact 1
Evaluate surgical intervention (uvulectomy) for patients with significant symptoms refractory to conservative management (Evidence: Expert opinion) 1References
1 Maïga A, Mourier G, Quinton L, Rouget C, Gales C, Denis C et al.. G protein-coupled receptors, an unexploited animal toxin targets: Exploration of green mamba venom for novel drug candidates active against adrenoceptors. Toxicon : official journal of the International Society on Toxinology 2012. link